Skip to main content
Top
Published in: Endocrine 1/2013

01-08-2013 | Original Article

Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation

Authors: Jie Wu, Jun-jie Wu, Lin-jun Yang, Li-xin Wei, Da-jin Zou

Published in: Endocrine | Issue 1/2013

Login to get access

Abstract

Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes. Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is found to have a protective effect on islet beta-cell. To date, the mechanism underlying the protective role of thiazolidinedione on beta-cell survival remain largely unknown. Activation of autophagy was detected by transmission electron microscopy, western blot, and GFP-LC3 transfection. Cell viability was examined by WST-8. Cell apoptosis was demonstrated by DAPI and Annexin V/PI staining. Colony formation assay was used to detect long-term cell viability. We demonstrated that rosiglitazone-treated beta-cells were more resistant to palmitate-induced apoptosis. The conversion of LC3-I to LC3-II and accumulated autophagosomes were found to be upregulated in rosiglitazone-treated cells. Inhibition of autophagy augmented palmitate-induced apoptosis with rosiglitazone treatment, suggesting that autophagy plays an important role in the survival function of rosiglitazone on beta-cells. Furthermore, we showed that rosiglitazone could induce AMP-activated protein kinase (AMPK) phosphorylation and reduce p70S6 kinase phosphorylation. Inhibition of AMPK impaired autophagy activation and enhanced palmitate-induced apoptosis during rosiglitazone treatment. These findings reveal that rosiglitazone-induced autophagy contributes to its protective function on beta-cells during palmitate treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference M.Y. Donath, P.A. Halban, Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47(3), 581–589 (2004)PubMedCrossRef M.Y. Donath, P.A. Halban, Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47(3), 581–589 (2004)PubMedCrossRef
2.
go back to reference I.W. Campbell, S. Mariz, Beta-cell preservation with thiazolidinediones. Diabetes Res. Clin. Pract. 76(2), 163–176 (2007)PubMedCrossRef I.W. Campbell, S. Mariz, Beta-cell preservation with thiazolidinediones. Diabetes Res. Clin. Pract. 76(2), 163–176 (2007)PubMedCrossRef
3.
go back to reference L.L. Baggio, D.J. Drucker, Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu. Rev. Med. 57, 265–281 (2006)PubMedCrossRef L.L. Baggio, D.J. Drucker, Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu. Rev. Med. 57, 265–281 (2006)PubMedCrossRef
4.
go back to reference B. Levine, D.J. Klionsky, Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6(4), 463–477 (2004)PubMedCrossRef B. Levine, D.J. Klionsky, Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6(4), 463–477 (2004)PubMedCrossRef
5.
6.
7.
go back to reference D.J. Klionsky, H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev, D.S. Askew, M. Baba, E.H. Baehrecke, B.A. Bahr, A. Ballabio, B.A. Bamber, D.C. Bassham, E. Bergamini, X. Bi, M. Biard-Piechaczyk, J.S. Blum, D.E. Bredesen, J.L. Brodsky, J.H. Brumell, U.T. Brunk, W. Bursch, N. Camougrand, E. Cebollero, F. Cecconi, Y. Chen, L.S. Chin, A. Choi, C.T. Chu, J. Chung, P.G. Clarke, R.S. Clark, S.G. Clarke, C. Clave, J.L. Cleveland, P. Codogno, M.I. Colombo, A. Coto-Montes, J.M. Cregg, A.M. Cuervo, J. Debnath, F. Demarchi, P.B. Dennis, P.A. Dennis, V. Deretic, R.J. Devenish, F. Di Sano, J.F. Dice, M. Difiglia, S. Dinesh-Kumar, C.W. Distelhorst, M. Djavaheri-Mergny, F.C. Dorsey, W. Droge, M. Dron, W.A. Dunn Jr, M. Duszenko, N.T. Eissa, Z. Elazar, A. Esclatine, E.L. Eskelinen, L. Fesus, K.D. Finley, J.M. Fuentes, J. Fueyo, K. Fujisaki, B. Galliot, F.B. Gao, D.A. Gewirtz, S.B. Gibson, A. Gohla, A.L. Goldberg, R. Gonzalez, C. Gonzalez-Estevez, S. Gorski, R.A. Gottlieb, D. Haussinger, Y.W. He, K. Heidenreich, J.A. Hill, M. Hoyer-Hansen, X. Hu, W.P. Huang, A. Iwasaki, M. Jaattela, W.T. Jackson, X. Jiang, S. Jin, T. Johansen, J.U. Jung, M. Kadowaki, C. Kang, A. Kelekar, D.H. Kessel, J.A. Kiel, H.P. Kim, A. Kimchi, T.J. Kinsella, K. Kiselyov, K. Kitamoto, E. Knecht, M. Komatsu, E. Kominami, S. Kondo, A.L. Kovacs, G. Kroemer, C.Y. Kuan, R. Kumar, M. Kundu, J. Landry, M. Laporte, W. Le, H.Y. Lei, M.J. Lenardo, B. Levine, A. Lieberman, K.L. Lim, F.C. Lin, W. Liou, L.F. Liu, G. Lopez-Berestein, C. Lopez-Otin, B. Lu, K.F. Macleod, W. Malorni, W. Martinet, K. Matsuoka, J. Mautner, A.J. Meijer, A. Melendez, P. Michels, G. Miotto, W.P. Mistiaen, N. Mizushima, B. Mograbi, I. Monastyrska, M.N. Moore, P.I. Moreira, Y. Moriyasu, T. Motyl, C. Munz, L.O. Murphy, N.I. Naqvi, T.P. Neufeld, I. Nishino, R.A. Nixon, T. Noda, B. Nurnberg, M. Ogawa, N.L. Oleinick, L.J. Olsen, B. Ozpolat, S. Paglin, G.E. Palmer, I. Papassideri, M. Parkes, D.H. Perlmutter, G. Perry, M. Piacentini, R. Pinkas-Kramarski, M. Prescott, T. Proikas-Cezanne, N. Raben, A. Rami, F. Reggiori, B. Rohrer, D.C. Rubinsztein, K.M. Ryan, J. Sadoshima, H. Sakagami, Y. Sakai, M. Sandri, C. Sasakawa, M. Sass, C. Schneider, P.O. Seglen, O. Seleverstov, J. Settleman, J.J. Shacka, I.M. Shapiro, A. Sibirny, E.C. Silva-Zacarin, H.U. Simon, C. Simone, A. Simonsen, M.A. Smith, K. Spanel-Borowski, V. Srinivas, M. Steeves, H. Stenmark, P.E. Stromhaug, C.S. Subauste, S. Sugimoto, D. Sulzer, T. Suzuki, M.S. Swanson, I. Tabas, F. Takeshita, N.J. Talbot, Z. Talloczy, K. Tanaka, I. Tanida, G.S. Taylor, J.P. Taylor, A. Terman, G. Tettamanti, C.B. Thompson, M. Thumm, A.M. Tolkovsky, S.A. Tooze, R. Truant, L.V. Tumanovska, Y. Uchiyama, T. Ueno, N.L. Uzcategui, I. van der Klei, E.C. Vaquero, T. Vellai, M.W. Vogel, H.G. Wang, P. Webster, J.W. Wiley, Z. Xi, G. Xiao, J. Yahalom, J.M. Yang, G. Yap, X.M. Yin, T. Yoshimori, L. Yu, Z. Yue, M. Yuzaki, O. Zabirnyk, X. Zheng, X. Zhu, R.L. Deter, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2), 151–175 (2008)PubMed D.J. Klionsky, H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev, D.S. Askew, M. Baba, E.H. Baehrecke, B.A. Bahr, A. Ballabio, B.A. Bamber, D.C. Bassham, E. Bergamini, X. Bi, M. Biard-Piechaczyk, J.S. Blum, D.E. Bredesen, J.L. Brodsky, J.H. Brumell, U.T. Brunk, W. Bursch, N. Camougrand, E. Cebollero, F. Cecconi, Y. Chen, L.S. Chin, A. Choi, C.T. Chu, J. Chung, P.G. Clarke, R.S. Clark, S.G. Clarke, C. Clave, J.L. Cleveland, P. Codogno, M.I. Colombo, A. Coto-Montes, J.M. Cregg, A.M. Cuervo, J. Debnath, F. Demarchi, P.B. Dennis, P.A. Dennis, V. Deretic, R.J. Devenish, F. Di Sano, J.F. Dice, M. Difiglia, S. Dinesh-Kumar, C.W. Distelhorst, M. Djavaheri-Mergny, F.C. Dorsey, W. Droge, M. Dron, W.A. Dunn Jr, M. Duszenko, N.T. Eissa, Z. Elazar, A. Esclatine, E.L. Eskelinen, L. Fesus, K.D. Finley, J.M. Fuentes, J. Fueyo, K. Fujisaki, B. Galliot, F.B. Gao, D.A. Gewirtz, S.B. Gibson, A. Gohla, A.L. Goldberg, R. Gonzalez, C. Gonzalez-Estevez, S. Gorski, R.A. Gottlieb, D. Haussinger, Y.W. He, K. Heidenreich, J.A. Hill, M. Hoyer-Hansen, X. Hu, W.P. Huang, A. Iwasaki, M. Jaattela, W.T. Jackson, X. Jiang, S. Jin, T. Johansen, J.U. Jung, M. Kadowaki, C. Kang, A. Kelekar, D.H. Kessel, J.A. Kiel, H.P. Kim, A. Kimchi, T.J. Kinsella, K. Kiselyov, K. Kitamoto, E. Knecht, M. Komatsu, E. Kominami, S. Kondo, A.L. Kovacs, G. Kroemer, C.Y. Kuan, R. Kumar, M. Kundu, J. Landry, M. Laporte, W. Le, H.Y. Lei, M.J. Lenardo, B. Levine, A. Lieberman, K.L. Lim, F.C. Lin, W. Liou, L.F. Liu, G. Lopez-Berestein, C. Lopez-Otin, B. Lu, K.F. Macleod, W. Malorni, W. Martinet, K. Matsuoka, J. Mautner, A.J. Meijer, A. Melendez, P. Michels, G. Miotto, W.P. Mistiaen, N. Mizushima, B. Mograbi, I. Monastyrska, M.N. Moore, P.I. Moreira, Y. Moriyasu, T. Motyl, C. Munz, L.O. Murphy, N.I. Naqvi, T.P. Neufeld, I. Nishino, R.A. Nixon, T. Noda, B. Nurnberg, M. Ogawa, N.L. Oleinick, L.J. Olsen, B. Ozpolat, S. Paglin, G.E. Palmer, I. Papassideri, M. Parkes, D.H. Perlmutter, G. Perry, M. Piacentini, R. Pinkas-Kramarski, M. Prescott, T. Proikas-Cezanne, N. Raben, A. Rami, F. Reggiori, B. Rohrer, D.C. Rubinsztein, K.M. Ryan, J. Sadoshima, H. Sakagami, Y. Sakai, M. Sandri, C. Sasakawa, M. Sass, C. Schneider, P.O. Seglen, O. Seleverstov, J. Settleman, J.J. Shacka, I.M. Shapiro, A. Sibirny, E.C. Silva-Zacarin, H.U. Simon, C. Simone, A. Simonsen, M.A. Smith, K. Spanel-Borowski, V. Srinivas, M. Steeves, H. Stenmark, P.E. Stromhaug, C.S. Subauste, S. Sugimoto, D. Sulzer, T. Suzuki, M.S. Swanson, I. Tabas, F. Takeshita, N.J. Talbot, Z. Talloczy, K. Tanaka, I. Tanida, G.S. Taylor, J.P. Taylor, A. Terman, G. Tettamanti, C.B. Thompson, M. Thumm, A.M. Tolkovsky, S.A. Tooze, R. Truant, L.V. Tumanovska, Y. Uchiyama, T. Ueno, N.L. Uzcategui, I. van der Klei, E.C. Vaquero, T. Vellai, M.W. Vogel, H.G. Wang, P. Webster, J.W. Wiley, Z. Xi, G. Xiao, J. Yahalom, J.M. Yang, G. Yap, X.M. Yin, T. Yoshimori, L. Yu, Z. Yue, M. Yuzaki, O. Zabirnyk, X. Zheng, X. Zhu, R.L. Deter, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2), 151–175 (2008)PubMed
8.
go back to reference S.W. Yu, S.H. Baek, R.T. Brennan, C.J. Bradley, S.K. Park, Y.S. Lee, E.J. Jun, K.J. Lookingland, E.K. Kim, H. Lee, J.L. Goudreau, S.W. Kim, Autophagic death of adult hippocampal neural stem cells following insulin withdrawal. Stem Cells 26(10), 2602–2610 (2008)PubMedCrossRef S.W. Yu, S.H. Baek, R.T. Brennan, C.J. Bradley, S.K. Park, Y.S. Lee, E.J. Jun, K.J. Lookingland, E.K. Kim, H. Lee, J.L. Goudreau, S.W. Kim, Autophagic death of adult hippocampal neural stem cells following insulin withdrawal. Stem Cells 26(10), 2602–2610 (2008)PubMedCrossRef
9.
go back to reference K. Sato, K. Tsuchihara, S. Fujii, M. Sugiyama, T. Goya, Y. Atomi, T. Ueno, A. Ochiai, H. Esumi, Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 67(20), 9677–9684 (2007)PubMedCrossRef K. Sato, K. Tsuchihara, S. Fujii, M. Sugiyama, T. Goya, Y. Atomi, T. Ueno, A. Ochiai, H. Esumi, Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 67(20), 9677–9684 (2007)PubMedCrossRef
10.
go back to reference P. Codogno, A.J. Meijer, Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12(Suppl 2), 1509–1518 (2005)PubMedCrossRef P. Codogno, A.J. Meijer, Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12(Suppl 2), 1509–1518 (2005)PubMedCrossRef
11.
go back to reference E. Corcelle, N. Djerbi, M. Mari, M. Nebout, C. Fiorini, P. Fenichel, P. Hofman, P. Poujeol, B. Mograbi, Control of the autophagy maturation step by the MAPK ERK and p38: lessons from environmental carcinogens. Autophagy 3(1), 57–59 (2007)PubMed E. Corcelle, N. Djerbi, M. Mari, M. Nebout, C. Fiorini, P. Fenichel, P. Hofman, P. Poujeol, B. Mograbi, Control of the autophagy maturation step by the MAPK ERK and p38: lessons from environmental carcinogens. Autophagy 3(1), 57–59 (2007)PubMed
12.
go back to reference K.Y. Hur, H.S. Jung, M.S. Lee, Role of autophagy in beta-cell function and mass. Diabetes Obes. Metab. 12(Suppl 2), 20–26 (2010)PubMedCrossRef K.Y. Hur, H.S. Jung, M.S. Lee, Role of autophagy in beta-cell function and mass. Diabetes Obes. Metab. 12(Suppl 2), 20–26 (2010)PubMedCrossRef
13.
go back to reference G. Las, O.S. Shirihai, The role of autophagy in beta-cell lipotoxicity and type 2 diabetes. Diabetes Obes. Metab. 12(Suppl 2), 15–19 (2010)PubMedCrossRef G. Las, O.S. Shirihai, The role of autophagy in beta-cell lipotoxicity and type 2 diabetes. Diabetes Obes. Metab. 12(Suppl 2), 15–19 (2010)PubMedCrossRef
14.
go back to reference J. Zhou, W. Zhang, B. Liang, M.C. Casimiro, D. Whitaker-Menezes, M. Wang, M.P. Lisanti, S. Lanza-Jacoby, R.G. Pestell, C. Wang, PPARgamma activation induces autophagy in breast cancer cells. Int. J. Biochem. Cell Biol. 41(11), 2334–2342 (2009)PubMedCrossRef J. Zhou, W. Zhang, B. Liang, M.C. Casimiro, D. Whitaker-Menezes, M. Wang, M.P. Lisanti, S. Lanza-Jacoby, R.G. Pestell, C. Wang, PPARgamma activation induces autophagy in breast cancer cells. Int. J. Biochem. Cell Biol. 41(11), 2334–2342 (2009)PubMedCrossRef
15.
go back to reference J. Yan, H. Yang, G. Wang, L. Sun, Y. Zhou, Y. Guo, Z. Xi, X. Jiang, Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling. Autophagy 6(1), 67–73 (2010)PubMedCrossRef J. Yan, H. Yang, G. Wang, L. Sun, Y. Zhou, Y. Guo, Z. Xi, X. Jiang, Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling. Autophagy 6(1), 67–73 (2010)PubMedCrossRef
16.
go back to reference E. Karaskov, C. Scott, L. Zhang, T. Teodoro, M. Ravazzola, A. Volchuk, Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147(7), 3398–3407 (2006)PubMedCrossRef E. Karaskov, C. Scott, L. Zhang, T. Teodoro, M. Ravazzola, A. Volchuk, Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147(7), 3398–3407 (2006)PubMedCrossRef
17.
go back to reference W. El-Assaad, J. Buteau, M.L. Peyot, C. Nolan, R. Roduit, S. Hardy, E. Joly, G. Dbaibo, L. Rosenberg, M. Prentki, Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144(9), 4154–4163 (2003)PubMedCrossRef W. El-Assaad, J. Buteau, M.L. Peyot, C. Nolan, R. Roduit, S. Hardy, E. Joly, G. Dbaibo, L. Rosenberg, M. Prentki, Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144(9), 4154–4163 (2003)PubMedCrossRef
18.
go back to reference C. Bauvy, P. Gane, S. Arico, P. Codogno, E. Ogier-Denis, Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp. Cell Res. 268(2), 139–149 (2001)PubMedCrossRef C. Bauvy, P. Gane, S. Arico, P. Codogno, E. Ogier-Denis, Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp. Cell Res. 268(2), 139–149 (2001)PubMedCrossRef
19.
go back to reference K. Komiya, T. Uchida, T. Ueno, M. Koike, H. Abe, T. Hirose, R. Kawamori, Y. Uchiyama, E. Kominami, Y. Fujitani, H. Watada, Free fatty acids stimulate autophagy in pancreatic beta-cells via JNK pathway. Biochem. Biophys. Res. Commun. 401(4), 561–567 (2010)PubMedCrossRef K. Komiya, T. Uchida, T. Ueno, M. Koike, H. Abe, T. Hirose, R. Kawamori, Y. Uchiyama, E. Kominami, Y. Fujitani, H. Watada, Free fatty acids stimulate autophagy in pancreatic beta-cells via JNK pathway. Biochem. Biophys. Res. Commun. 401(4), 561–567 (2010)PubMedCrossRef
20.
go back to reference R.K. Amaravadi, D. Yu, J.J. Lum, T. Bui, M.A. Christophorou, G.I. Evan, A. Thomas-Tikhonenko, C.B. Thompson, Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117(2), 326–336 (2007)PubMedCrossRef R.K. Amaravadi, D. Yu, J.J. Lum, T. Bui, M.A. Christophorou, G.I. Evan, A. Thomas-Tikhonenko, C.B. Thompson, Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117(2), 326–336 (2007)PubMedCrossRef
21.
go back to reference V.R. Solomon, H. Lee, Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur. J. Pharmacol. 625(1–3), 220–233 (2009)PubMedCrossRef V.R. Solomon, H. Lee, Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur. J. Pharmacol. 625(1–3), 220–233 (2009)PubMedCrossRef
22.
go back to reference B. Ravikumar, C. Vacher, Z. Berger, J.E. Davies, S. Luo, L.G. Oroz, F. Scaravilli, D.F. Easton, R. Duden, C.J. O’Kane, D.C. Rubinsztein, Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36(6), 585–595 (2004)PubMedCrossRef B. Ravikumar, C. Vacher, Z. Berger, J.E. Davies, S. Luo, L.G. Oroz, F. Scaravilli, D.F. Easton, R. Duden, C.J. O’Kane, D.C. Rubinsztein, Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36(6), 585–595 (2004)PubMedCrossRef
23.
go back to reference Z. Feng, H. Zhang, A.J. Levine, S. Jin, The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102(23), 8204–8209 (2005)PubMedCrossRef Z. Feng, H. Zhang, A.J. Levine, S. Jin, The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102(23), 8204–8209 (2005)PubMedCrossRef
24.
go back to reference D.T. Finegood, M.D. McArthur, D. Kojwang, M.J. Thomas, B.G. Topp, T. Leonard, R.E. Buckingham, Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50(5), 1021–1029 (2001)PubMedCrossRef D.T. Finegood, M.D. McArthur, D. Kojwang, M.J. Thomas, B.G. Topp, T. Leonard, R.E. Buckingham, Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50(5), 1021–1029 (2001)PubMedCrossRef
25.
go back to reference J.W. Kim, J.H. Yang, H.S. Park, C. Sun, S.H. Lee, J.H. Cho, C.W. Yang, K.H. Yoon, Rosiglitazone protects the pancreatic beta-cell death induced by cyclosporine A. Biochem. Biophys. Res. Commun. 390(3), 763–768 (2009)PubMedCrossRef J.W. Kim, J.H. Yang, H.S. Park, C. Sun, S.H. Lee, J.H. Cho, C.W. Yang, K.H. Yoon, Rosiglitazone protects the pancreatic beta-cell death induced by cyclosporine A. Biochem. Biophys. Res. Commun. 390(3), 763–768 (2009)PubMedCrossRef
26.
go back to reference B.H. Chung, C. Li, B.K. Sun, S.W. Lim, K.O. Ahn, J.H. Yang, Y.H. Choi, K.H. Yoon, A. Sugawara, S. Ito, J. Kim, C.W. Yang, Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. Am. J. Transplant. 5(8), 1856–1867 (2005)PubMedCrossRef B.H. Chung, C. Li, B.K. Sun, S.W. Lim, K.O. Ahn, J.H. Yang, Y.H. Choi, K.H. Yoon, A. Sugawara, S. Ito, J. Kim, C.W. Yang, Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. Am. J. Transplant. 5(8), 1856–1867 (2005)PubMedCrossRef
27.
go back to reference C.Y. Lin, T. Gurlo, L. Haataja, W.A. Hsueh, P.C. Butler, Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J. Clin. Endocrinol. Metab. 90(12), 6678–6686 (2005)PubMedCrossRef C.Y. Lin, T. Gurlo, L. Haataja, W.A. Hsueh, P.C. Butler, Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J. Clin. Endocrinol. Metab. 90(12), 6678–6686 (2005)PubMedCrossRef
28.
go back to reference C. Ebato, T. Uchida, M. Arakawa, M. Komatsu, T. Ueno, K. Komiya, K. Azuma, T. Hirose, K. Tanaka, E. Kominami, R. Kawamori, Y. Fujitani, H. Watada, Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 8(4), 325–332 (2008)PubMedCrossRef C. Ebato, T. Uchida, M. Arakawa, M. Komatsu, T. Ueno, K. Komiya, K. Azuma, T. Hirose, K. Tanaka, E. Kominami, R. Kawamori, Y. Fujitani, H. Watada, Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 8(4), 325–332 (2008)PubMedCrossRef
29.
go back to reference S.E. Choi, S.M. Lee, Y.J. Lee, L.J. Li, S.J. Lee, J.H. Lee, Y. Kim, H.S. Jun, K.W. Lee, Y. Kang, Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 150(1), 126–134 (2009)PubMedCrossRef S.E. Choi, S.M. Lee, Y.J. Lee, L.J. Li, S.J. Lee, J.H. Lee, Y. Kim, H.S. Jun, K.W. Lee, Y. Kang, Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 150(1), 126–134 (2009)PubMedCrossRef
30.
go back to reference R. Scherz-Shouval, Z. Elazar, Regulation of autophagy by ROS: physiology and pathology. Trends Biochem. Sci. 36(1), 30–38 (2011)PubMedCrossRef R. Scherz-Shouval, Z. Elazar, Regulation of autophagy by ROS: physiology and pathology. Trends Biochem. Sci. 36(1), 30–38 (2011)PubMedCrossRef
31.
go back to reference W.X. Ding, H.M. Ni, W. Gao, T. Yoshimori, D.B. Stolz, D. Ron, X.M. Yin, Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171(2), 513–524 (2007)PubMedCrossRef W.X. Ding, H.M. Ni, W. Gao, T. Yoshimori, D.B. Stolz, D. Ron, X.M. Yin, Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171(2), 513–524 (2007)PubMedCrossRef
32.
go back to reference M. Cnop, M. Igoillo-Esteve, D.A. Cunha, L. Ladriere, D.L. Eizirik, An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem. Soc. Trans. 36(Pt 5), 909–915 (2008)PubMedCrossRef M. Cnop, M. Igoillo-Esteve, D.A. Cunha, L. Ladriere, D.L. Eizirik, An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem. Soc. Trans. 36(Pt 5), 909–915 (2008)PubMedCrossRef
33.
go back to reference A.J. Molina, J.D. Wikstrom, L. Stiles, G. Las, H. Mohamed, A. Elorza, G. Walzer, G. Twig, S. Katz, B.E. Corkey, O.S. Shirihai, Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58(10), 2303–2315 (2009)PubMedCrossRef A.J. Molina, J.D. Wikstrom, L. Stiles, G. Las, H. Mohamed, A. Elorza, G. Walzer, G. Twig, S. Katz, B.E. Corkey, O.S. Shirihai, Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58(10), 2303–2315 (2009)PubMedCrossRef
34.
go back to reference P. Schrauwen, M.K. Hesselink, Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53(6), 1412–1417 (2004)PubMedCrossRef P. Schrauwen, M.K. Hesselink, Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53(6), 1412–1417 (2004)PubMedCrossRef
35.
go back to reference K. Morino, K.F. Petersen, G.I. Shulman, Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55(Suppl 2), S9–S15 (2006)PubMedCrossRef K. Morino, K.F. Petersen, G.I. Shulman, Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55(Suppl 2), S9–S15 (2006)PubMedCrossRef
36.
go back to reference M. Qatanani, M.A. Lazar, Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21(12), 1443–1455 (2007)PubMedCrossRef M. Qatanani, M.A. Lazar, Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21(12), 1443–1455 (2007)PubMedCrossRef
37.
go back to reference M. Masini, M. Bugliani, R. Lupi, S. del Guerra, U. Boggi, F. Filipponi, L. Marselli, P. Masiello, P. Marchetti, Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52(6), 1083–1086 (2009)PubMedCrossRef M. Masini, M. Bugliani, R. Lupi, S. del Guerra, U. Boggi, F. Filipponi, L. Marselli, P. Masiello, P. Marchetti, Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52(6), 1083–1086 (2009)PubMedCrossRef
38.
go back to reference H.Y. Xiong, X.L. Guo, X.X. Bu, S.S. Zhang, N.N. Ma, J.R. Song, F. Hu, S.F. Tao, K. Sun, R. Li, M.C. Wu, L.X. Wei, Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell. Cancer Lett. 288(1), 68–74 (2010) H.Y. Xiong, X.L. Guo, X.X. Bu, S.S. Zhang, N.N. Ma, J.R. Song, F. Hu, S.F. Tao, K. Sun, R. Li, M.C. Wu, L.X. Wei, Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell. Cancer Lett. 288(1), 68–74 (2010)
39.
go back to reference L. Yu, A. Alva, H. Su, P. Dutt, E. Freundt, S. Welsh, E.H. Baehrecke, M.J. Lenardo, Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304(5676), 1500–1502 (2004) L. Yu, A. Alva, H. Su, P. Dutt, E. Freundt, S. Welsh, E.H. Baehrecke, M.J. Lenardo, Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304(5676), 1500–1502 (2004)
40.
go back to reference G. Kroemer, B. Levine, Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9(12), 1004–1010 (2008) G. Kroemer, B. Levine, Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9(12), 1004–1010 (2008)
41.
go back to reference C.H. Jung, S.H. Ro, J. Cao, N.M. Otto, D.H. Kim, mTOR regulation of autophagy. FEBS Lett. 584(7), 1287–1295 (2010)PubMedCrossRef C.H. Jung, S.H. Ro, J. Cao, N.M. Otto, D.H. Kim, mTOR regulation of autophagy. FEBS Lett. 584(7), 1287–1295 (2010)PubMedCrossRef
42.
go back to reference D. Han, B. Yang, L.K. Olson, A. Greenstein, S.H. Baek, K.J. Claycombe, J.L. Goudreau, S.W. Yu, E.K. Kim, Activation of autophagy through modulation of 5′-AMP-activated protein kinase protects pancreatic beta-cells from high glucose. Biochem J 425(3), 541–551 (2010)PubMedCrossRef D. Han, B. Yang, L.K. Olson, A. Greenstein, S.H. Baek, K.J. Claycombe, J.L. Goudreau, S.W. Yu, E.K. Kim, Activation of autophagy through modulation of 5′-AMP-activated protein kinase protects pancreatic beta-cells from high glucose. Biochem J 425(3), 541–551 (2010)PubMedCrossRef
43.
go back to reference M. Stumvoll, Thiazolidinediones—some recent developments. Expert Opin. Investig. Drugs 12(7), 1179–1187 (2003)PubMedCrossRef M. Stumvoll, Thiazolidinediones—some recent developments. Expert Opin. Investig. Drugs 12(7), 1179–1187 (2003)PubMedCrossRef
44.
go back to reference M. Jiang, S. Fernandez, W.G. Jerome, Y. He, X. Yu, H. Cai, B. Boone, Y. Yi, M.A. Magnuson, P. Roy-Burman, R.J. Matusik, S.B. Shappell, S.W. Hayward, Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ. 17(3), 469–481 (2010)PubMedCrossRef M. Jiang, S. Fernandez, W.G. Jerome, Y. He, X. Yu, H. Cai, B. Boone, Y. Yi, M.A. Magnuson, P. Roy-Burman, R.J. Matusik, S.B. Shappell, S.W. Hayward, Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ. 17(3), 469–481 (2010)PubMedCrossRef
45.
go back to reference D.F. Mahmood, I. Jguirim-Souissi, H. el Khadija, N. Blondeau, V. Diderot, S. Amrani, M.N. Slimane, T. Syrovets, T. Simmet, M. Rouis, Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis. J. Biol. Chem. 286(33), 28858–28866 (2011)PubMedCrossRef D.F. Mahmood, I. Jguirim-Souissi, H. el Khadija, N. Blondeau, V. Diderot, S. Amrani, M.N. Slimane, T. Syrovets, T. Simmet, M. Rouis, Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis. J. Biol. Chem. 286(33), 28858–28866 (2011)PubMedCrossRef
46.
go back to reference L. Cerquetti, C. Sampaoli, D. Amendola, B. Bucci, L. Masuelli, R. Marchese, S. Misiti, A. De Venanzi, M. Poggi, V. Toscano, A. Stigliano, Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells. Exp. Cell Res. 317(10), 1397–1410 (2011)PubMedCrossRef L. Cerquetti, C. Sampaoli, D. Amendola, B. Bucci, L. Masuelli, R. Marchese, S. Misiti, A. De Venanzi, M. Poggi, V. Toscano, A. Stigliano, Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells. Exp. Cell Res. 317(10), 1397–1410 (2011)PubMedCrossRef
47.
go back to reference L.G. Fryer, A. Parbu-Patel, D. Carling, The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277(28), 25226–25232 (2002)PubMedCrossRef L.G. Fryer, A. Parbu-Patel, D. Carling, The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277(28), 25226–25232 (2002)PubMedCrossRef
48.
go back to reference D.H. van Raalte, M. Diamant, Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res. Clin. Pract. 93(Suppl 1), S37–005346 (2011)PubMedCrossRef D.H. van Raalte, M. Diamant, Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res. Clin. Pract. 93(Suppl 1), S37–005346 (2011)PubMedCrossRef
Metadata
Title
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation
Authors
Jie Wu
Jun-jie Wu
Lin-jun Yang
Li-xin Wei
Da-jin Zou
Publication date
01-08-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9826-5

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine